Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis

As of 2026-06-24, the Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis is open. You can check whether you qualify with the free 1-minute eligibility self-check below.

Last verified: 2026-06-24

Am I eligible for the Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis?

A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkin’s lymphoma.

How do I join the Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis?

1. Run the free 1-minute eligibility self-check.
2. If you qualify, register your claim on the platform.
3. Class members typically pay nothing unless money is recovered.

Other active class actions

• Inferior Vena Cava IVC Filter Class Action
• Johnson and Johnson Ovarian Cancer Class Action
• 911 Fees Class Action
• Barrick Pascua-Lama Class Action
• Bernzomatic Gas Torch Defect Class Action
• Canadian Standards Association/Standards Council of Canada Class Actio
• Chevy & Cadillac Defective Transmissions – GM Class Action Canada
• Chrysler Ignition Class Action
• Dodge Chrysler Tire Sensor Defect Class Action
• Eliquis Class Action
• Essure Permanent Birth Control Class Action
• Fiat Chrysler Diesel Emissions Class Action

← Browse all 3196+ class actions

This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.